Lee's Pharmaceutical Holdings Limited (00950.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.14

From 52W high−53.46%

Volume799000.00

Market capHKD 712.49M

P/E (TTM)4.3x

P/S (TTM)0.4x

Div yield1.90%

Key dataSep 18, 2026

Open

HKD 1.14

From 52W high

−53.46%

Volume

799000.00

Market cap

HKD 712.49M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.4x

P/E (TTM)

4.3x

RSI (14)

54.1

MomentumView details →

1D Return

+6.61%

YTD Return

−20.39%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

4.3x

EV/EBITDA

2.4x

EV/Sales

0.2x

P/S (TTM)

0.4x

P/B (TTM)

0.3x

ProfitabilityView details →

Gross Margin

53.75%

Net Margin

8.64%

EBITDA Margin

8.98%

ROE (TTM)

7.87%

ROA (TTM)

4.80%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+34.78%

EPS YoY

+70.30%

FCF YoY

+27.17%

Revenue CAGR 3Y

+5.21%

EPS CAGR 3Y

+22.47%

EBITDA YoY

−34.13%

MomentumView details →

1D Return

+6.61%

YTD Return

−20.39%

1Y Return

−51.21%

RSI (14)

54.1

vs 50D SMA

+5.66%

vs 200D SMA

−6.26%

Capital & dividendView details →

Debt/Equity

0.12x

Current Ratio

1.06x

Quick Ratio

0.69x

Div Yield

1.90%

Div Rate

HKD 0.02

Div Growth 1Y

+56.67%

EarningsView details →

EPS (Actual)

HKD 0.16

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.94B

Net Income (TTM)

167.27M

Op. CF (TTM)

577.42M

Next earningsMar 30, 2027 →

Latest newsMore news →

Lee's Pharmaceutical Holdings declared an interim dividend of HK$0.035 per share for the six months ended June 2026, up 59.1% from HK$0.022 per share in the prior-year period.20d ago

Lee's Pharmaceutical Holdings issued a profit alert, expecting its interim net profit attributable to shareholders to rise 26-41% year-on-year to HK$85-95 million, driven by revenue growth and improved gross margin.24d ago

Similar companies

Collegium Pharmaceutical, Inc.COLL Ironwood Pharmaceuticals, Inc.IRWD Pak Fah Yeow International Limited00239.HK Esperion Therapeutics, Inc.ESPR Fusen Pharmaceutical Company Limited01652.HK Zhongzhi Pharmaceutical Holdings Limited03737.HK Find similar companies →

Latest newsMore news →

Lee's Pharmaceutical Holdings declared an interim dividend of HK$0.035 per share for the six months ended June 2026, up 59.1% from HK$0.022 per share in the prior-year period.20d ago Lee's Pharmaceutical Holdings issued a profit alert, expecting its interim net profit attributable to shareholders to rise 26-41% year-on-year to HK$85-95 million, driven by revenue growth and improved gross margin.24d ago Lee's Pharmaceutical's new drug clinical trial application for its proprietary ADC project ZK2401 was accepted by the Center for Drug Evaluation of China's National Medical Products Administration on 2026-07-29.52d ago